Solutions – Pharmaceutical 2018-03-25T21:10:52+00:00

Secure Product Dossiers Shared with
Third Parties


With patent cliffs and rising generic competition, your pharmaceutical company is spending more on inventions and new drug research than ever before. Securing this intellectual property is vital to your long-term growth and business strategy. And as your organization gets ‘flatter’ and borderless, you regularly collaborate with many external parties such as CROs, API manufacturers, laboratories, university scientists, clinical trial companies – the list is endless. This collaboration and outsourcing is accompanied by a heavy exchange of confidential information across the firewall. Since this information is often shared without any security or controls, it is highly vulnerable to leakage. Learn how to protect this vital data in your organization.

Download Business Use Case

Data-Centric Protection for Your IP Wherever it Travels

There are many areas where sensitive data can be vulnerable to data loss. Scroll over the six departments in the diagram below to see where your pharmaceutical company may be at exposed to risk.

Rights Management Can Help Your Pharmaceutical Company Meet Compliance Regulations

Seclore’s Rights Management helps ensure that your information is always secure, even when sending data to external agencies, sharing data via the cloud or accessing it on mobile devices. Granular usage permissions (view, edit, print, copy, run macros, screen capture) can be applied to a file and updated at any time from any location even with previously shared information. And all usage information is tracked for real-time audit trails to meet compliance regulations. No longer do you have to worry about internal employees, business partners or vendors leaking data – whether it’s accidental or malicious. Your data remains safe at all times.



This biopharmaceutical company delivers solutions ranging from discovery-led in-house R&D programs, drug development through clinical and non-clinical research and integrated research services to leading global pharmaceutical and biotechnology companies. Their quest for innovation, required them to prevent their confidential intellectual property, research and legal agreements from unauthorized access.